| name | design-preterm-labor-prevention-plan |
| description | Use when managing preterm birth risk — e.g., "preventing preterm labor", "short cervix in pregnancy", "progesterone injections pregnancy", "history of preterm birth", "cerclage for short cervix" |
| source | ACOG Practice Bulletin 234 (2021); Romero et al. AJOG 2012 (vaginal progesterone); Fonseca et al. NEJM 2007 (cervical length + progesterone) |
| tags | ["pregnancy","preterm-birth","progesterone","cervical-length","cerclage","prevention","health"] |
| verified | true |
Design Preterm Labor Prevention Plan
Apply risk-stratified interventions — progesterone, cervical monitoring, and cerclage — to reduce preterm birth.
Why This Is Best Practice
Adopted by: ACOG, SMFM, RCOG — risk-stratified prevention is the standard of care for women with identified preterm birth risk factors.
Impact: Progesterone therapy reduces preterm birth before 34 weeks by 33–45% in high-risk women (Cochrane 2013, 36 RCTs). Short cervix (<25 mm at 16–24 weeks) with vaginal progesterone reduces preterm delivery <33 weeks by 58% (Fonseca et al., NEJM 2007).
Why best: Preterm birth is the leading cause of neonatal mortality and morbidity globally. Most cases are not preventable, but identifiable risk factors allow targeted intervention.
Steps
- Risk stratification at first visit:
- High risk: prior spontaneous preterm birth <37 weeks (strongest predictor, 20–30% recurrence)
- Moderate risk: uterine anomalies, prior LEEP/cone biopsy, short cervix in prior pregnancy, smoking, underweight, multiple prior D&Cs
- Multiple gestation: separate high-risk category; interventions differ
- Prior preterm birth (singleton):
- Start 17-alpha-hydroxyprogesterone caproate (17-OHPC, Makena) 250 mg IM weekly from weeks 16–20 through 36 weeks
- OR vaginal progesterone 200 mg/night (evidence equivalent; patient preference)
- Universal cervical length screening (weeks 18–24):
- Transvaginal ultrasound (TVU) cervical length — standard of care in many centers
- Cervical length <25 mm → offer vaginal progesterone 200 mg/night
- Short cervix with prior preterm birth:
- Cervical length <25 mm + prior spontaneous PTB → offer cerclage (surgical cervical suture); SMFM 2020
- Signs of preterm labor — educate patient to recognize:
- Regular contractions before 37 weeks (>4/hour)
- Lower back pain, pelvic pressure, vaginal discharge change
- Any signs before 37 weeks → go to L&D triage same day
- For cerclage patients: remove at 36–37 weeks; no intercourse or vaginal exams that could dislodge suture.
Rules
- 17-OHPC evidence was contested by FDA in 2023 — discuss current evidence with MFM before prescribing; vaginal progesterone remains well-supported.
- Do not use tocolytics (nifedipine, indomethacin) as long-term prevention — they are for acute preterm labor only.
- Cervical length shortening is often asymptomatic — it is only detectable by TVU, not clinical exam.
Examples
Prior 33-week delivery (singleton): Cervical length check at 16, 18, 20, 22 weeks; start vaginal progesterone at 16 weeks; cerclage if CL <25 mm at 18 weeks.
Asymptomatic short cervix (22 mm at 20 weeks), no prior PTB: Start vaginal progesterone 200 mg nightly; re-check CL in 2–3 weeks.
Common Mistakes
- Waiting for symptoms to start intervention — by the time contractions begin, cervix may already be dilated.
- Using multiple gestation protocols for singleton — progesterone does not prevent preterm birth in multiples (increases risk in some studies).
- Not referring to MFM for cerclage decision — cerclage has specific indications; placing without criteria increases preterm labor risk.
Health Disclaimer: Preterm birth prevention requires specialist involvement. Refer to a maternal-fetal medicine (MFM) specialist for cervical length <25 mm, prior preterm birth, or any suspected preterm labor. Go to L&D triage for any contractions before 37 weeks.